Octreotide LAR / Sandostatin LAR (LAR=long acting release) ( DrugBank: Octreotide )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
84サルコイドーシス1

84. サルコイドーシス


臨床試験数 : 149 薬物数 : 202 - (DrugBank : 78) / 標的遺伝子数 : 66 - 標的パスウェイ数 : 169
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2013-005376-17-NL
(EUCTR)
20/06/201427/02/2014Sandostatin therapy in sarcoidosisSandostatin therapy in sarcoidosis - SST in SA Sarcoidosis
MedDRA version: 16.1;Level: HLGT;Classification code 10003816;Term: Autoimmune disorders;System Organ Class: 10021428 - Immune system disorders;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
Trade Name: Sandostatin LAR
INN or Proposed INN: OCTREOTIDE
Other descriptive name: octreotide LAR / Sandostatin LAR (LAR=long acting release)
Erasmus Medical CenterNULLNot RecruitingFemale: yes
Male: yes
Netherlands